Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone. (Q40873486)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

multiple drug resistance

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Thomas Litman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

D Nielsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Eriksen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Kjaersgaard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Plesner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Friche

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Skovsgaard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

363-370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Catalytic function of DNA topoisomerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Cellular resistance to cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Major vault protein LRP-related multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Mechanisms of resistance to topoisomerases poisons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

The sequence of a cDNA encoding the major vault protein from Rattus norvegicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

ATPase activity of purified multidrug resistance-associated protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

The catalytic cycle of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Morphologic alterations in drug sensitive vs. drug resistant cells due to cytostatic application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

Reduced levels of topoisomerase II? and II? in a multidrug-resistant lung-cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900337-3

10.1016/S0006-2952(00)00337-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856431%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference